Jayagopal Ashwath 4
4 · Opus Genetics, Inc. · Filed Mar 18, 2026
Research Summary
AI-generated summary of this filing
Opus Genetics (IRD) CSO Jayagopal Ashwath Sells Shares
What Happened
- Jayagopal Ashwath, Chief Scientific & Development Officer of Opus Genetics (IRD), had 3,719 shares disposed on March 16, 2026. The shares were sold for a weighted average price of $5.12 per share, generating proceeds of approximately $19,046.
- This sale was an automatic transaction to satisfy tax withholding obligations related to the vesting/settlement of restricted stock units (RSUs), not a discretionary open-market trade by the insider.
Key Details
- Transaction date: March 16, 2026; Form 4 filed March 18, 2026 (timely filed).
- Price: weighted average $5.12; individual sale prices ranged from $5.11 to $5.1301. The shares were sold in multiple transactions.
- Shares sold: 3,719; proceeds ≈ $19,046.
- Shares owned after transaction: not specified in the provided excerpt.
- Notable footnotes: F1 — sale was automatic to satisfy tax withholding from an RSU vesting/settlement (not discretionary). F2 — weighted average price reported; issuer/SEC staff can request the per-trade price breakdown.
Context
- This was a tax-withholding sale tied to RSU settlement (transaction code typically F), which is a routine administrative event and does not necessarily signal the insider’s view of the company.
- No option exercise, gift, or 10% owner change is involved; it reflects fulfillment of tax obligations on vested equity.
Insider Transaction Report
Form 4
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
Transactions
- Sale
Common Stock
[F1][F2]2026-03-16$5.12/sh−3,719$19,046→ 516,775 total
Footnotes (2)
- [F1]The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
- [F2]The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.11 to $5.1301, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Amy Rabourn, by Power of Attorney|2026-03-18